| 000 | 01700 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513211150.0 | ||
| 264 | 0 | _c20000621 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0268-3369 | ||
| 024 | 7 |
_a10.1038/sj.bmt.1702339 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFavre-Schmuziger, G | |
| 245 | 0 | 0 |
_aTreatment of solid tumors following allogeneic bone marrow transplantation. _h[electronic resource] |
| 260 |
_bBone marrow transplantation _cApr 2000 |
||
| 300 |
_a895-8 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xetiology |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma in Situ _xetiology |
| 650 | 0 | 4 |
_aCarcinoma, Papillary _xetiology |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeiomyosarcoma _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeoplasms, Second Primary _xetiology |
| 650 | 0 | 4 |
_aOsteosarcoma _xetiology |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHofer, S | |
| 700 | 1 | _aPassweg, J | |
| 700 | 1 | _aTichelli, A | |
| 700 | 1 | _aHoffmann, T | |
| 700 | 1 | _aSpeck, B | |
| 700 | 1 | _aHerrmann, R | |
| 700 | 1 | _aGratwohl, A | |
| 773 | 0 |
_tBone marrow transplantation _gvol. 25 _gno. 8 _gp. 895-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bmt.1702339 _zAvailable from publisher's website |
| 999 |
_c10760075 _d10760075 |
||